secwatch.observer — SEC 8-K summary
======================================

Issuer:     MERIT MEDICAL SYSTEMS INC (MMSI)
CIK:        0000856982
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0000856982-26-000020
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Merit Medical Systems provides historical revenue by new product categories for 2022-2025
--------------------------------------------------------------------------------

- Total revenue grew from $1.151B in 2022 to $1.516B in 2025, with foundational revenue at $1.029B and therapeutic at $487M in 2025.
- Therapeutic revenue increased 24% year-over-year in 2025, driven by cardiac therapies ($93.4M), endoscopy ($72.5M), and oncology ($96.8M).
- Foundational revenue rose to $1.029B in 2025 from $862M in 2022, with access ($588.5M) and OEM ($167.1M) as top platforms.
- Quarterly total revenue rose sequentially from $355M in Q1 2025 to $394M in Q4 2025, with therapeutic platform growing each quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856982/000085698226000020/0000856982-26-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856982/000085698226000020/mmsi-20260413x8k.htm
  HTML page:      https://secwatch.observer/filing/0000856982-26-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer